Work

Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer.

Year: 1999

Type: article

Source: PubMed

Authors: W K Oh, P W Kantoff

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2467627677

FWCI: 2.555

Cites:

Cited by: 16

Related to: 10